Collegium Pharmaceutical, Inc. reported strong Q4 results last week where the company easily beat on the bottom line and grew ...

Though A&Z Pharmaceutical has grown steadily over the years, the company’s mission has stayed the same: working diligently to ...

Qomel Company’s CEO Hisham Alagla said that construction of the new pharmaceutical plant nears completion. Production is ...

Drug prices have remained high as the federal government's plan to introduce zero tariffs on pharmaceutical products drags.

Manns said Bayer “urgently” needed to reduce its net financial debt. The consensus forecast from analysts is that, despite a radical dividend cut in 2024, debt declined by only €1.2bn to €33.3bn at ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the acquisition and launch1 of Acetylcysteine Injection, 6 gm/30 mL ...

METiS Pharmaceuticals, a clinical-stage, AI-driven biotechnology company specializing in innovative drug delivery ...

Net sales down 10.0% to €911.9 million, driven by lower volumes for Sanofi and the suspension of production at Brindisi, only ...

India's largest drugmaker by revenue Sun Pharmaceutical is aiming to launch its experimental anti-obesity and type 2 diabetes ...

Glenmark Pharmaceuticals acquires and launches Acetylcysteine Injection in the US market, strengthening its injectable ...

Kuehne+Nagel supports Sanofi in multiple countries worldwide, including Hungary, the UK, and the UAE, by providing customised ...